López-Maguey RP, Trujillo-Ortiz L, Morales-Montor G, Pérez-Becerra R, Staufert-Gutiérrez J, Pacheco-Gahbler C, Parraguirre-Martínez S, Martínez-Hernández H, Pérez MGMD

Language: Spanish
References: 19
Page: 389-396
PDF size: 452.92 Kb.

ABSTRACT

Background: Renal cell carcinoma with translocation on chromosome Xp11.2 was recognized in 2004 by the World Health Organization. That neoplasia is associated with different micro-arrangements, particularly of the TFE3 gene on the Xp11 chromosome. Prevalence of the translocation varies from 1-1.6% of all kidney tumors in the adult population.
Clinic case: A 64-year-old woman presented with moderate left lumbar pain radiating to the ipsilateral upper quadrant two months prior to hospital admission. Computed tomography urogram identified a heterogeneous tumor at the lower pole and middle portion of the left kidney that measured 20 × 17 × 14 cm, with irregular edges and calcifications. There was bilateral perihilar lymph node enlargement adjacent to the aorta that anteriorly displaced the vena cava. Laboratory tests reported hemoglobin of 10g/dL and calcium of 9.2 mEq/dL. Open radical nephrectomy with para-aortic lymphadenectomy was performed, revealing abundant lymph nodes in the mesentery and in the contralateral renal hilum. Pathology study diagnosis was renal carcinoma with Xp11.2 translocation (immunohistochemistry positive for TFE-3), with metastasis to one lymph node. The patient is currently undergoing the fourth cycle of chemotherapy with pazopanib, with disease dissemination to the lungs, mesentery, and cervical region.
Conclusion: Renal cell carcinoma with Xp11.2 translocation usually affects children and young adults. It does not cause symptoms and the kidney masses are painless. Given that the majority of cases are diagnosed at late stages, outcome is unfavorable.

REFERENCES

1. Al-Maghrabi AJ, et al. Uncommon localization of extrarenal xp11.2 translocation-associated renal cell carcinoma (RCC): Case report. Appl Immunohistochem Mol Morphol 2017. DOI: 10.1097/PAI.0000000000000576

2. Lim B, et al. Clinicopathological features of Xp11.2 translocation renal cell carcinoma. Korean J Urol 2015;56(3):212- 217. DOI: 10.4111/kju.2015.56.3.212

3. Hirobe M, et al. Clinicopathological characteristics of Xp11.2 translocation renal cell carcinoma in adolescents and adults: Diagnosis using immunostaining of transcription factor E3 and fluorescence in situ hybridization analysis. Int J Urol 2016;23(2):140-145. DOI: 10.1111/iju.13007

4. Liu N, et al. Renal cell carcinoma associated with Xp11.2 translocation /TFE3 gene fusions: clinical features, treatments and prognosis. Plos One 2016;11(11):e0166897. DOI: 10.1371/journal.pone.0166897

5. Kakoki K, et al. Long-term treatment with sequential molecular targeted therapy for Xp11.2 translocation renal cell carcinoma: A case report and review of the literature. Clin Genitourin Cancer 2017;15(3):e503-e506. DOI: 10.1016/j. clgc.2016.12.026

6. Choo MS, et al. Clinicopathologic characteristics and prognosis of Xp11.2 translocation renal cell carcinoma: multicenter, propensity score matching analysis. Clin Genitourin Cancer 2017;15(5):e819-e825. DOI: 10.1016/j. clgc.2017.04.015

7. Manucha V, et al. Cyto-histological correlation of Xp11.2 translocation/TFE3 gene fusion associated renal cell carcinoma: Report of a case with review of literature. Diagn Cytopathol 2018;46(3):267-270. DOI: 10.1002/dc.23839

8. Liu J, et al. Xp11.2 translocation renal cell carcinoma with multiple bone metastases: A case report. Oncol Letters 2016;11(3):2233-2236. DOI: 10.3892/ol.2016.4211

9. Classe M, et al. Incidence, clinicopathologic features and fusion transcript of translocation renal cell carcinomas. Histopathology 2017;70(7):1089-1097. DOI: 10.1111/ his.13167

10. Chen X, et al. Renal cell carcinoma associated with Xp11.2 translocation/TFE gene fusion: imaging findings in 21 patients. Eur Radiol 2017;27(2):543-552. DOI: 10.1007/ s00330-016-4421-4

11. Ahluwalia P, et al. Renal cell carcinoma associated with Xp 11.2 Translocation/TFE3 gene fusion: A rare case report with review of the literature. Hindawi Publishing Corporation. Case Rep Urol 2013;2013:810590. DOI: 10.1155/2013/810590

12. D´Antonio A, et al. Unsuspected Xp11 translocation renal neoplasm associated with contralateral clear cell carcinoma. Int J Surg Pathol 2016;24(3):248-252. DOI: 10.1177/1066896915597753

13. Asaki HE, et al. Xp11.2 translocation tumor: A rare cause of gross hematuria. JAAPA 2014;27(2):24-27. DOI: 10.1097/01.JAA.0000442700.87975.0b

14. Parihar A, et al. Xp11 translocation renal cell carcinoma morphologically mimicking clear cel-papillary renal cell carcinoma in an adult patient: report of a case expanding the morphologic spectrum of xp11 translocation renal cell carcinomas. Int J Surg Pathol 2015;23(3):243-7. DOI: 10.1177/1066896914562280

15. Nishimura K, et al. A case of metastatic Xp11.2 translocation renal cell carcinoma successfully managed by cytoreductive nephrectomy followed by axitinib therapy. Mol Clin Oncol 2017;6(3):362-364. DOI: 10.3892/mco.2017.1142

16. Wang Z, et al. Postoperative recurrence of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion. J Int Med Res 2017;45(4):1287-1296. DOI: 10.1177/0300060517711358

17. Liang W, et al. Xp11.2 translocation renal cell carcinoma with egg-shell calcification mimicking a benign renal tumour: A case report. Oncol Letters 2015;10(5):3191-3194. DOI: 10.3892/ol.2015.3718

18. Quiñonez-Urrego E, et al. Carcinoma renal asociado con translocacion Xp11. Analisis de dos casos del adulto, uno de ellos con presentación primaria como metástasis ovárica. Patol Rev Latinoamer 2013;51(4):239-243. Dirección URL: .

19. Akhavein A, et al. Xp11 translocation renal cell carcinoma: unusual variant masquerading as upper tract urothelial cell carcinoma. Urol Case Rep 2014;2(3):75-77. DOI: 10.1016/j. eucr.2014.02.003